A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Patil, Manish Pandey, Vedang Murthy et al.|Cancer|2019Cited by 133
Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective studyShwetabh Sinha, Sarbani Ghosh Laskar, Jai Prakash Agarwal et al.|Head & Neck|2020Cited by 7
Six-year follow-up from the weekly-three-weekly study comparing cisplatin once-a-week to once-every-three-weeks as concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma.Vanita Noronha, Kumar Prabhash, Vijay Patil et al.|Journal of Clinical Oncology|2022Cited by 3